EP3104860
PHARMACEUTICAL COMPOUNDS AS CHK1 INHIBITORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
9.2.2015EP published:
30.12.2020EP application number:
15746362.1
EPO information:
European Patent Register
Max expiry date:
8.2.2035
Title:
PHARMACEUTICAL COMPOUNDS AS CHK1 INHIBITORS
Timeline
Today
9.2.2015EP application
30.12.2020EP Publication
Owner
Name:
Sentinel Oncology LimitedAddress:
181 Science Park Milton Road, Cambridge Cambridgeshire CB4 0GJ, GB
Inventor
Name:
BOYLE, Robert GeorgeAddress:
Cambridge, UK CB4 0EY, GB
Name:
WALKER, David WinterAddress:
Cambridge, UK CB4 0EY, GB
Name:
BOYCE, Richard JustinAddress:
Cambridge, UK CB4 0EY, GB
Name:
PETERSON, ScottAddress:
Seattle, WA 98121, US
Name:
FAROUZ, FrancineAddress:
Seattle, WA 98121, US
Name:
VO, Cong HungAddress:
Seattle, WA 98121, US
Priority
Number:
201402277Date:
10.2.2014Country:
GB
Number:
201462083687 PDate:
24.11.2014Country:
US
Classification
Categories:
A61K 31/4965, A61K 31/497, C07D 403/12, A61P 35/00